Intermittent Versus Continuous Glucose Monitoring in Intensive Care Unit

NANot yet recruitingINTERVENTIONAL
Enrollment

200

Participants

Timeline

Start Date

July 31, 2025

Primary Completion Date

June 30, 2026

Study Completion Date

December 31, 2026

Conditions
Critical IllnessHyperglycaemiaHypoglycaemia
Interventions
DEVICE

Continuous glucose monitoring

Intravenous insulin therapy will be guided by interstitial glucose measurements using DexcomG7 continuous glucose monitor. Confirmatory blood glucose tests will be performed daily. In extreme clinical conditions (post-resuscitation, pH \< 7.20, severe hypoxia, severe haemodynamic compromise), confirmatory blood tests will be performed in 2 hour intervals until clinical improvement.

DIAGNOSTIC_TEST

Control Arm - standard of care

Intravenous insulin dosing will be guided according to blood glucose measurements using RadiometerABL800 (standard of care). DexcomG7 continuous glucose monitor will be applied in blinded mode for interstitial glucose monitoring for later CGM metrics and comparison analysis.

Trial Locations (1)

Unknown

University Medical Center Ljubljana, Ljubljana

All Listed Sponsors
lead

University Medical Centre Ljubljana

OTHER